Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 17.5B | 15.8B | 12.1B | 11.5B |
Cost of revenue | 9.5B | 8.3B | 6.8B | 6.5B |
Gross profit | 8.0B | 7.4B | 5.4B | 5.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 4.1B | 4.1B | 2.6B | 2.3B |
Operating income | 1.5B | 955M | 1.2B | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 679.2M | 582.5M | 413.2M | 491.5M |
Other income expense | — | — | — | — |
Pretax income | 755.3M | 312.6M | 821.5M | 807.1M |
Tax provision | 87.7M | 183.3M | 204.6M | 212.2M |
Net income | 667.6M | 129.3M | 616.9M | 594.9M |
Basic EPS | — | 5.4 | 27.2 | 24.8 |
Diluted EPS | — | 5.4 | 27.2 | 24.8 |
Basic average shares | — | 23.9M | 22.6M | 21.4M |
Diluted average shares | — | 23.9M | 22.6M | 21.4M |
EBITDA | 2.5B | 2.1B | 2.0B | 2.0B |
Net income from continuing op. | — | — | — | — |
Minority interests | 0 | 0 | 0 | -63M |
Preferred stock dividends | 0 | 0 | 0 | 0 |